The real residual risk in patients with cardiovascular disease and diabetes: the promise of epigenetics.
25 August 2018 (15:35 - 15:50)
Organised by:
About the speaker
AmsterdamUMC location AMC, Amsterdam (Netherlands (The))
4 More presentations in this session
Doctor J. Plutzky (Boston, US)
A clinical view on BET inhibition in targeting residual risk in cardiovascular disease and diabetes.
Professor K. Ray (London, GB)
Access the full session
The Event
ESC Congress 2018
25 August 2018
15:35 CET
